Tudományos publikáció


Ágh, T., van Boven, J. F., & Kardas, P. (2023). Europe’s cost of living crisis jeopardises medication adherenceBMJ 2023;380:p747. Link


Ágh, T., Hadžiabdić, M. O., Garuoliene, K., Granas, A. G., Aarnio, E., Menditto, E., ... & European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE). (2022). Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA StudyFrontiers in pharmacology13, 892240.

Kardas, P., Bago, M., Barnestein-Fonseca, P., Garuolienė, K., Granas, A. G., Gregório, J., ... & Ágh, T. (2022). Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges. Frontiers in pharmacology13, 944829.

Balázs, P. G., Erdősi, D., Zemplényi, A., & Brodszky, V. (2022). Time trade-off health state utility values for depression: a systematic review and meta-analysis. Quality of Life Research, 1-15. Link

Marcell Csanádi, Zoltán Kaló, Maureen Rutten-van Molken, Willemijn Looman, Mirjana Huic, Darija Ercevic, Dragana Atanasijevic, László Lorenzovici, Paweł Petryszyn, Gábor Pogány, János Pitter, Antal Zemplényi. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy, Link

Elek, P., Csanádi, M., Fadgyas-Freyler, P., Gervai, N., Oross-Bécsi, R., Szécsényi-Nagy, B., ... & Zemplényi, A. (2022). Heterogeneous impact of the COVID-19 pandemic on lung, colorectal and breast cancer incidence in Hungary: results from time series and panel data models. BMJ open12(8), e061941. Link

Dimitrova M, Jakab I, Mitkova Z, Kamusheva M, Tachkov K, Nemeth B, Zemplenyi A, Dawoud D, Delnoij DMJ, Houýez F and Kalo Z (2022). Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries. Frontiers in Public Health 10:922708. doi: 10.3389/fpubh.2022.922708. Link

Tachkov, K. T., Zemplényi, A., Kamusheva, M. S., Dimitrova, M. J., Siirtola, P., Pontén, J., ... & Petrova, G. I. (2022). Barriers to use Artificial Intelligence methodologies in Health Technology Assessment in Central and East European countries. Frontiers in Public Health, 2170. Link

Zemplényi, A., Józwiak-Hagymásy, J., Kovács, S., Erdősi, D., Boncz, I., Tényi, T., Osváth, P., & Vörös, V. (2022). Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorderBMC Psychiatry 22, 437. Link

Kamusheva, M., Németh, B., Zemplényi, A., Kaló, Z., Elvidge, J., Dimitrova, M., ... & Mitkova, Z. (2022). Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers. Journal of Comparative Effectiveness Research, (0). Link

Elek, P., Fadgyas-Freyler, P., Váradi, B., Mayer, B., Zemplényi, A., & Csanádi, M. (2022). Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. Link

Kovács, S., Kaló, Z., Daubner-Bendes, R., Kolasa, K., Hren, R., Tesar, T., Reckers-Droog, V., Brouwer, W., Federici, C., Drummond, M., & Zemplényi, A. T. (2022). Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries. Health Economics, 1–12. Link

Kovács, S., Németh, B., Erdősi, D., Brodszky, V., Boncz, I., Kaló, Z., & Zemplényi, A. (2022). Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?Applied Health Economics and Health Policy, 1-13. Link


Kaló, Z., Németh, B., & Zemplényi, A. (2021). Can cost-effectiveness principles be ignored in urgent times?Journal of comparative effectiveness research, 10.2217/cer-2021-0211. Advance online publication. Link

Blankart, C. R., Dams, F., Penton, H., Kaló, Z., Zemplényi, A., Shatrov, K., ... & Federici, C. (2021). Regulatory and HTA early dialogues in medical devices. Health Policy. Link

Inotai, A., Ágh, T., Maris, R., Erdősi, D., Kovács, S., Conceptualisation, Z. K., & Senkus, E. (2021). Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer. Cancer Treatment Reviews, 102264. Link

Daubner-Bendes Rita, Kovács Sándor, Niewada Maciej, Huic Mirjana, Drummond Michael, Ciani Oriana, Blankart Carl Rudolf, Mandrik Olena, Torbica Aleksandra, Yfantopoulos John, Petrova Guenka, Holownia-Voloskova Malwina, Taylor Rod S., Al Maiwenn, Piniazhko Oresta, Lorenzovici László, Tarricone Rosanna, Zemplényi Antal, Kaló Zoltán (2021). Quo Vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges. Frontiers in public health, 8, 994. Link

Zemplényi Antal Tamás, Csikós Ágnes, Fadgyas‐Freyler Petra, Csanádi Marcell, Kaló Zoltán, Pozsgai Éva, Rutten‐van Mölken Maureen, Pitter János György. (2021). Early palliative care associated with lower costs for adults with advanced cancer: evidence from Hungary. European Journal of Cancer Care, e13473. Link


Grigore Bogdan, Ciani Oriana, Dams Florian, Federici Carlo, de Groot Saskia, Möllenkamp Meilin, Rabbe Stefan, Shatrov Kosta, Zemplenyi Antal, Taylor Rod S. Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. PharmacoEconomics 38, 1055–1070 (2020).

Kovács S, Tóth M, Janszky J, Dóczi T, Fabó D, Boncz I, Botz L, Zemplényi A. Cost-effectiveness analysis of invasive EEG monitoring in drug-resistant epilepsy. Epilepsy Behav. 2020 Nov 27:107488. doi: 10.1016/j.yebeh.2020.107488. Epub ahead of print. PMID: 33257296.

Zemplényi AT, Csikós Á, Csanádi M, Mölken MR, Hernandez C, Pitter JG, Czypionka T, Kraus M, Kaló Z. Implementation of palliative care consult Service in Hungary - integration barriers and facilitators. BMC Palliat Care. 2020 Mar 27;19(1):41. doi: 10.1186/s12904-020-00541-0. PMID: 32220251; PMCID: PMC7102442.

Erőss, B., Molnár, Z., Szakács, Z., Zádori, N., Szakó, L., Váncsa, S. Zemplényi A., ... & Hegyi, P. (2020). Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial. Trials, 21(1), 1-9.

Kaló, Z., Zemplényi, A., Rutten-Van Molken, M., Looman, W., Huić, M., & Tandara, R. (2020). Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries. Croatian Medical Journal, 61(3), 252.


Zemplenyi, A. T., Kalo, Z., Kovacs, G., Farkas, R., Beöthe, T., Bányai, D., ... & Mangel, L. (2018). Cost‐effectiveness analysis of intensity‐modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer. European journal of cancer care27(1), e12430.


Konferencia absztrakt


Vida, R. G., Bella, R., Kovács, S., Erdősi, D., Józwiak-Hagymásy, J., Zemplényi, A., Vörös, V., & Osváth, P. (2022). Efficacy of High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depressive Disorder After Two Pharmacotherapy Treatment Failure: Meta-analysis of Randomized Sham Controlled Trials  Value in Health25(1), S193.

Zemplényi, A., Józwiak-Hagymásy, J., Kovács, S., Erdősi, D., Kónyi, A., & Voros, V. (2022). POSA257 Repetitive Transcranial Magnetic Stimulation Is a Cost-Effective Alternative in Patients with Major Depressive Disorder After Two Treatment Failures. Evidence from Hungary. Value in Health25(1), S170.

Erdősi, D., Agh, T., Vajda, P., Zemplényi, A., Kovács, S., & Inotai, A. (2022). POSB376 Limited Published Quantitative Evidence on Medication Adherence of Multimorbid Elderly Women with Polypharmacotherapy: Results of a Systematic Literature Review. Value in Health25(1), S234.


Kovács, S., Bendes, R., Kaló, Z., Kolasa, K., Hren, R., Tesar, T., ... & Zemplényi, A. (2021). PNS77 Transferring Health Technology Assessments from EARLY Adopter to Late Adopter Countries: Recommendations for the Implementation of CED Schemes in Central and Eastern European Countries. Value in Health, 24, S187.


Kovács, S., Erdősi, D., Németh, B., & Zemplényi, A. (2020). PNS25 Multi-level Cost-Effectiveness Thresholds in Europe-Results of a Systematic Literature Review and Supplementary Research. Value in Health, 23, S648.